Doug Bain, founder and consulting partner of ClinFlo, discusses his proposed regulatory blueprint for digital trials in the latest episode of The Scope of Things podcast. With host Deborah Borfitz, Bain delves into his strategy for turning 21 CFR Part 11 into a more practical regulation that streamlines rather than bogs down clinical trials, what would qualify someone to take on the role as a trusted third party (and what makes them trustworthy), and the new FDA administration’s modernization...
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from The Scope of Things
Episode: 51 - Bridging the Equity Gap in Oncology with Eugene Manley, Jr.
Episode: 50 - Ramona Burress and Cassandra O’Neal on Health Equity That Works
Episode: 49 - Mike Sullivan on AI and Clinical Operations in the Year 2030
Episode: 48 - Florence Mowlem on the Challenges and Solutions of Pediatric Rare Disease Trials
Get summaries like this every morning.
Free AI-powered recaps of The Scope of Things and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.